Tag Archives: immunotherapy

zoom
cheddar
-

Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and OncoSec’s role in the fight to end cancer. We discuss the advantages of intratumoral therapy, the future of cancer care, and how OncoSec is positioned to solve a great unmet need in oncology. Check out the full interview for more!

zoom
diversity, workforce, immigration, millennials, donald trump, biotech, healthcare, technology, innovation
-

Why Diversity Is Essential

In President Donald Trump’s address to joint sessions of Congress, he announced the White House is planning to unveil a new executive order on immigration tailored to respond to recent court rulings. As you may know, federal judges put a hold on the President’s original executive order banning travelers from seven majority-Muslim countries to enter the US.

Continue reading

zoom
sunset
-

A Patient’s Perspective

Immunotherapy is changing the way we perceive and treat cancer. Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the immune system to fight disease. Melinda Welsh documented her diagnosis and treatment of squamous cell carcinoma of the head and neck with ImmunoPulse IL-12 in the Los Angeles Times.

zoom
Immunotherapy: Block, Tackle & Punch
-

Doctor, Quit Yellen at Janet

Last month, the Chair of the Federal Reserve, Janet Yellen, made headline news when she weighed in on stock valuations in her semiannual monetary policy report. In her testimony before the Senate Banking Committee, Dr. Yellen made the following statement:

Continue reading

zoom
I feel a leader should be approachable
-

2014 Annual Letter To OncoSec Shareholders

A Letter to Our Shareholders

This is an important moment in cancer immunotherapy and we believe OncoSec is poised to make a real impact. During this pivotal time, it is important that we outline the core fundamentals of our company and our technology, so that you as shareholders will understand why all of us here at OncoSec are excited for the future.

Continue reading

zoom
Cancer Immunotherapy
-

2014 Is Poised to be a Breakout Year for Cancer Immunotherapy

In the December 2013 issue of Science, Cancer Immunotherapy was named as the Breakthrough of the Year.   My initial reaction to this was a little shocking and wondering what finally swayed the sceptics to realize this?  Internally, we have been calling it a breakthrough for sometime, what did we mean by calling it a breakthrough in the first place?

Continue reading

-

Sachs Cancer Bio Partnering Forum

130522 sachs_associates

The Sachs Cancer Bio Partnering Forum, presented by Sachs Associates, brings together business and scientific leaders from cancer research institutes, advocacy groups, pharmaceutical companies and biotech corporations, to assist in investment and funding opportunities. With over 300 representatives in these areas, this year’s presentations covered a wide range of topics, over the span of the two-day event.

Continue reading

-

Blossom Ball Raises Over $150K for Cancer Research

cy13-gala-marysville-header216050

On May 11, I was honored to be involved with hosting the Annual American Cancer Society’s (ACS) Blossom Ball with my family, OncoSec Medical was one of the sponsors and together we helped raise over $150,000 for cancer research and funding. As a biopharmaceutical company developing advanced-stage immunotherapy to treat skin cancer, I believe it is very important to be involved as an individual and represent OncoSec Medical with both the ACS and the group CEO’s Against Cancer. Below is an excerpt from the speech I gave that night at the fundraiser, providing an outline on the CEO’s Against Cancer program.

Continue reading